These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22817666)
21. Frequency and etiology of tubulo-interstitial nephritis in an adult renal biopsies in a tertiary renal care hospital: A single-center study. Qureshi R; Imtiaz S; Dhrolia M; Ahmad A Saudi J Kidney Dis Transpl; 2020; 31(2):335-341. PubMed ID: 32394905 [TBL] [Abstract][Full Text] [Related]
22. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report. Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725 [TBL] [Abstract][Full Text] [Related]
23. Combination Cyclophosphamide/Glucocorticoids Provide Better Tolerability and Outcomes versus Glucocorticoids Alone in Patients with Sjogren's Associated Chronic Interstitial Nephritis. Shen Y; Xie J; Lin L; Li X; Shen P; Pan X; Ren H; Chen N Am J Nephrol; 2017; 46(6):473-480. PubMed ID: 29241210 [TBL] [Abstract][Full Text] [Related]
24. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury. Hatakeyama Y; Horino T; Matsumoto T; Terada Y; Okuhara Y Clin Exp Nephrol; 2021 Oct; 25(10):1087-1092. PubMed ID: 34089392 [TBL] [Abstract][Full Text] [Related]
25. Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study. Broder A; Mowrey WB; Khan HN; Jovanovic B; Londono-Jimenez A; Izmirly P; Putterman C Semin Arthritis Rheum; 2018 Feb; 47(4):545-551. PubMed ID: 28803673 [TBL] [Abstract][Full Text] [Related]
26. Acute interstitial nephritis - a reappraisal and update. Raghavan R; Eknoyan G Clin Nephrol; 2014 Sep; 82(3):149-62. PubMed ID: 25079860 [TBL] [Abstract][Full Text] [Related]
27. Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy. Suzuki K; Miura N; Imai H Clin Exp Nephrol; 2014 Aug; 18(4):606-12. PubMed ID: 24052158 [TBL] [Abstract][Full Text] [Related]
28. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709 [TBL] [Abstract][Full Text] [Related]
30. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Saeki T; Kawano M; Mizushima I; Yamamoto M; Wada Y; Ubara Y; Nakashima H; Ito T; Yamazaki H; Narita I; Saito T Clin Exp Nephrol; 2016 Feb; 20(1):87-93. PubMed ID: 26141243 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic roles of urinary kidney injury molecule 1 and soluble C5b-9 in acute tubulointerstitial nephritis. Zhao WT; Huang JW; Sun PP; Su T; Tang JW; Wang SX; Liu G; Yang L Am J Physiol Renal Physiol; 2019 Sep; 317(3):F584-F592. PubMed ID: 31291122 [TBL] [Abstract][Full Text] [Related]
32. Tubulointerstitial nephritis and uveitis syndrome (TINU) with Fanconi's syndrome. Yao YH; Lin CC; Chung YM; Yang AH; Li SY; Lin CC; Lin YP; Yang WC; Yang CY Clin Nephrol; 2011 Feb; 75 Suppl 1():75-8. PubMed ID: 21269599 [TBL] [Abstract][Full Text] [Related]
33. Presentation, diagnosis, and treatment outcome of tuberculous-mediated tubulointerstitial nephritis. Chapagain A; Dobbie H; Sheaff M; Yaqoob MM Kidney Int; 2011 Mar; 79(6):671-677. PubMed ID: 21160461 [TBL] [Abstract][Full Text] [Related]